Ligand Enters Into OmniAb® Platform License Agreement with Tizona Therapeutics

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/3/2026

1. SNOW
2. AVGO
3. RARE
4. HPE
5. FIVE
6. SPY
7. VRTS
8. NTAP
9. NTSK
10. OLLI

Go back to Ligand Enters Into OmniAb® Platform License Agreement with Tizona Therapeutics
LIGAND PHARMA (NASDAQ: LGND) Delayed: 289.74 +2.82 (0.98%)
Previous Close $286.92    52 Week High $139.79 
Open $286.92    52 Week Low $82.07 
Day High $290.09    P/E 673.81 
Day Low $281.88    EPS $0.43 
Volume 190,686